RxSight, Inc. (RXST)

6.77 -0.40 (-5.58%) USD  |  NASDAQ  |  Apr 29, 14:04
More

RxSight Research and Development Expense (TTM) : 38.55M for Dec. 31, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for RXST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Alphatec Holdings, Inc. 75.82M
Abbott Laboratories 2.943B
Accuray, Inc. 44.10M
Boston Scientific Corp. 2.125B
Plus Therapeutics, Inc. 8.379M